GJA9 Antikörper (Middle Region)

Produktnummer ABIN2774869

Der Kaninchen Polyklonal Anti-GJA9-Antikörper wurde für WB validiert. Er ist geeignet, GJA9 in Proben von Human und Hund zu detektieren. Es ist 1 Publikation verfügbar.

Kurzübersicht für GJA9 Antikörper (Middle Region) (ABIN2774869)

Target: GJA9 (Gap Junction Protein, alpha 9, 59kDa (GJA9))

Reaktivität: Human, Hund

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser GJA9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-GJA9 Antikörper

Bindungsspezifität: Middle Region

Sequenz: IDGENNMRQS PQTVFSLPAN CDWKPRWLRA TWGSSTEHEN RGSPPKGNLK

Homologie: Dog: 86%, Human: 100%

Produktmerkmale: This is a rabbit polyclonal antibody against GJA9. It was validated on Western Blot using a cell lysate as a positive control.

Aufreinigung: Affinity Purified

Immunogen: The immunogen is a synthetic peptide directed towards the middle region of human GJA9

Anwendungsinformationen

Applikationshinweise: Optimal working dilutions should be determined experimentally by the investigator.

Kommentare:

Antigen size: 515 AA

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freeze-thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Referenzen für anti-GJA9 Antikörper (ABIN2774869)

Terrier-Lacombe, Guillou, Maire, Terrier, Vince, de Saint Aubain Somerhausen, Collin, Pedeutour, Coindre: "Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group." in: The American journal of surgical pathology, Vol. 27, Issue 1, pp. 27-39, (2002) (PubMed).

Details zu GJA9

Target: GJA9 (Gap Junction Protein, alpha 9, 59kDa (GJA9))

Andere Bezeichnung: GJA9

Hintergrund: Connexins, such as GJA9, are involved in the formation of gap junctions, intercellular conduits that directly connect the cytoplasms of contacting cells. Each gap junction channel is formed by docking of 2 hemichannels, each of which contains 6 connexin subunits.Connexins, such as GJA9, are involved in the formation of gap junctions, intercellular conduits that directly connect the cytoplasms of contacting cells. Each gap junction channel is formed by docking of 2 hemichannels, each of which contains 6 connexin subunits (Sohl et al., 2003 [PubMed 12881038]).[supplied by OMIM]. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-612 BI463634.1 7-618 613-1929 AF271261.1 585-1901 1930-2331 BU689816.1 1-402 c
Alias Symbols: CX58, CX59, GJA10, MGC50985
Protein Interaction Partner: GRB2,
Protein Size: 515

Molekulargewicht: 59 kDa

Gen-ID: 81025

NCBI Accession: NM_030772, NP_110399

UniProt: P57773